Mirae Asset Global ETFs Holdings
DYN icon

Mirae Asset Global ETFs Holdings’s Dyne Therapeutics DYN Stock Holding History

Mirae Asset Global ETFs Holdings’s Portfolio DYN Stock Details DYN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.68M Buy
76,195
+726
+1% +$13.5K ﹤0.01% 1347
2026
Q1 		$1.35M Buy
75,469
+4,278
+6% +$73.8K ﹤0.01% 1369
2025
Q4 		$1.39M Buy
71,191
+9,556
+16% +$181K ﹤0.01% 1345
2025
Q3 		$777K Buy
61,635
+4,825
+8% +$55K ﹤0.01% 1639
2025
Q2 		$541K Buy
56,810
+344
+0.6% +$3.79K ﹤0.01% 1784
2025
Q1 		$597K Buy
56,466
+2,886
+5% +$41.3K ﹤0.01% 1769
2024
Q4 		$1.26M Buy
53,580
+2,903
+6% +$85.9K ﹤0.01% 1421
2024
Q3 		$1.81M Buy
50,677
+11,037
+28% +$439K ﹤0.01% 1192
2024
Q2 		$1.4M Buy
+39,640
New +$1.15M ﹤0.01% 1265

Other funds holding DYN

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $29.1B AUM 60.8% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $881M AUM 160.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Mirae Asset Global ETFs Holdings's DYN Position: Q2 2026 in Review

Mirae Asset Global ETFs Holdings increased its Dyne Therapeutics (DYN) stake by 0.96% in Q2 2026, buying an estimated $13.5K and bringing the position to 76,195 shares worth $1.68M. The position accounts for ﹤0.01% of the portfolio, ranked #1347.

Mirae Asset Global ETFs Holdings first reported a position in DYN in Q2 2024 and has held it in 9 quarters since. The position peaked at $1.81M in Q3 2024. 245 funds tracked by Wall St. Rank hold DYN as of Q2 2026.

  • Mirae Asset Global ETFs Holdings held 76,195 shares of Dyne Therapeutics worth $1.68M as of Q2 2026.
  • Mirae Asset Global ETFs Holdings bought 726 Dyne Therapeutics shares in Q2 2026, an estimated $13.5K.
  • Dyne Therapeutics made up ﹤0.01% of Mirae Asset Global ETFs Holdings's portfolio in Q2 2026, its #1347 holding.
  • Mirae Asset Global ETFs Holdings first reported a position in Dyne Therapeutics in Q2 2024 and has held it in 9 quarters since.
  • Mirae Asset Global ETFs Holdings's Dyne Therapeutics position peaked at $1.81M in Q3 2024.
  • 245 funds tracked by Wall St. Rank held Dyne Therapeutics as of Q2 2026.

Based on Mirae Asset Global ETFs Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.